> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CBER Laboratory Quality System Praised
- URL: https://www.fdaweb.com/cber-laboratory-quality-system-praised/
- Published: 2016-02-17T12:00:00.000Z
- Updated: 2026-09-15T02:36:28.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5134795

> CBER director **Peter Marks** says that the Center’s Laboratory Quality System (LQS) program is an international leader in biological product regulation based on demonstrated expertise in laboratory techniques. Writing in an *FDA Voice* blog [post](http://blogs.fda.gov/fdavoice/index.php/2016/02/cbers-laboratory-quality-system-management-helps-keep-biological-product-standards-high/?ref=fdaweb.com), Marks says the LQS “is the coordinated structure, procedures, processes, and resources that the Center uses to evaluate and test CBER-regulated biological products.” He says that LQS product testing supports biological product licensing, lot release, and surveillance of licensed biological products and other Center actions.  
>  
> In 2010, Marks says, CBER received American Association for Laboratory Accreditation accreditation for six methods to test influenza vaccines and seven methods for evaluating blood donor screening kits. Additional methods have been accredited since then, he says. The 12/2015 accreditation renewal demonstrated the Center’s competence in 32 test methods previously accredited and added a new laboratory test evaluating a cELISA allergen test used by the Center for cat hair, ragweed, and dust mites in the new-accredited Laboratory of Immunobiochemistry, the post says.